Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck

Journal of Clinical Oncology

Volumn 22, Issue 19, 2004, Pages 3965-3972

  Wreesmann, Volkert B ^a   Shi, Weiji ^a   Thaler, Howard T ^a   Poluri, Ashok ^a   Kraus, Dennis H ^a   Pfister, David ^a   Shaha, Ashok R ^a   Shah, Jatin P ^a   Rao, Pulivarthi H ^a   Singh, Bhuvanesh ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SURVIVAL; CHROMOSOME 11Q; CHROMOSOME 12Q; CHROMOSOME 21Q; CHROMOSOME 5Q; CHROMOSOME 6Q; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; GENE AMPLIFICATION; GENE IDENTIFICATION; HEAD AND NECK CARCINOMA; HUMAN; MONTE CARLO METHOD; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; AGED; DISEASE FREE SURVIVAL; FEMALE; GENETICS; HEAD AND NECK TUMOR; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PROPORTIONAL HAZARDS MODEL; SURVIVAL;

AGED; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MONTE CARLO METHOD; NUCLEIC ACID HYBRIDIZATION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 5444264596     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.01.094     Document Type: Article

References (37)

1. Maier H, Dietz A, Gewelke U, et al: Tobacco and alcohol and the risk of head and neck cancer. Clin Investig 70:320-327, 1992
2. Shah JP, Lydiatt W: Treatment of cancer of the head and neck. CA Cancer J Clin 45:352-368, 1995
3. Lydiatt WM, Shah JP, Hoffman HT: AJCC stage groupings for head and neck cancer: Should we look at alternatives? A report of the Head and Neck Sites Task Force. Head Neck 23:607-612, 2001
4. Sidransky D: Molecular genetics of head and neck cancer. Curr Opin Oncol 7:229-233, 1995
5. Estilo CL, O-Charoenrat P, Ngai I, et al: The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue. Clin Cancer Res 9:2300-2306, 2003
6. Kallioniemi A, Kallioniemi OP, Sudar D, et al: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821, 1992
7. Speicher MR, Howe C, Crotty P, et al: Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res 55:1010-1013, 1995
8. Redon R, Muller D, Caulee K, et al: A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains. Cancer Res 61:4122-4129, 2001
9. Singh B, Reddy PG, Goberdhan A, et al: p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas. Genes Dev 16:984-993, 2002
10. Singh B, Gogineni SK, Sacks PG, et al: Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification. Cancer Res 61:4506-4513, 2001
11. Bockmuhl U, Schluns K, Kuchler I, et al: Genetic imbalances with impact on survival in head and neck cancer patients. Am J Pathol 157:369-375, 2000
12. Ashman JN, Patmore HS, Condon LT, et al: Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridization. Br J Cancer 89:864-869, 2003
13. Benjamini Y, Hochburg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B 57:289-300, 1995
14. Reiner A, Yekutieli D, Benjamini Y: Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19:368-375, 2003
15. Jain AN, Chin K, Borresen-Dale AL, et al: Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival. Proc Natl Acad Sci U S A 98:7952-7957, 2001
16. Wreesmann VB, Ghossein RA, Patel SG, et al: Genome-wide appraisal of thyroid cancer progression. Am J Pathol 161:1549-1556, 2002
17. Wessels LF, van Welsem T, Hart AA, et al: Molecular classification of breast carcinomas by comparative genomic hybridization: A specific somatic genetic profile for BRCA1 tumors. Cancer Res 62:7110-7117, 2002
18. An International System for Human Cytogenetic Nomenclature (1985) ISCN 1985: Report of the Standing Committee on Human Cytogenetic Nomenclature. Birth Defects Orig Artic Ser 21:1-117, 1985
19. Kallioniemi OP, Kallioniemi A, Piper J, et al: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10:231-243, 1994
20. Cahill DP, Kinzler KW, Vogelstein B, et al: Genetic instability and Darwinian selection in tumours. Trends Cell Biol 9:M57-60, 1999
21. Califano J, van der Riet P, Westra W, et al: Genetic progression model for head and neck cancer: Implications for field cancerization. Cancer Res 56:2488-2492, 1996
22. Bockmuhl U, Petersen S, Schmidt S, et al: Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas. Cancer Res 57:5213-5216, 1997
23. Bockmuhl U, Wolf G, Schmidt S, et al: Genomic alterations associated with malignancy in head and neck cancer. Head Neck 20:145-151, 1998
24. Kutler D, Wreesmann VB, Goberdhan A, et al: Human papilloma virus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst 95:1718-1722, 2003
25. Singh B, Wreesmann VB, Pfister D, et al: Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposure. BMC Genet 3:22, 2002
26. Shinozaki H, Ozawa S, Ando N, et al: Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin Cancer Res 2:1155-1161, 1996
27. Bellacosa A, Almadori G, Cavallo S, et al: Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: Prognostic significance and clinical implications. Clin Cancer Res 2:175-180, 1996
28. Donnellan R, Chetty R: Cyclin D1 and human neoplasia. Mol Pathol 51:1-7, 1998
29. Sauter ER, Nesbit M, Litwin S, et al: Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas. Cancer Res 59:4876-4881, 1999
30. Brookes S, Lammie GA, Schuuring E, et al: Amplified region of chromosome band 11q13 in breast and squamous cell carcinomas encompasses three CpG islands telomeric of FGF3, including the expressed gene EMS1. Genes Chromosomes Cancer 6:222-231, 1993
31. Huang X, Gollin SM, Raja S, et al: High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci U S A 99:11369-11374, 2002
32. Harris CP, Lu XY, Narayan G, et al: Comprehensive molecular cytogenetic characterization of cervical cancer cell lines. Genes Chromosomes Cancer 36:233-241, 2003
33. Balsara BR, Testa JR: Chromosomal imbalances in human lung cancer. Oncogene 21:6877-6883, 2002
34. Fitzsimmons SA, Ireland H, Barr NI, et al: Human squamous cell carcinomas lose a mortality gene from chromosome 6q14.3 to q15. Oncogene 22:1737-1746, 2003
35. Belbin TJ, Singh B, Barber I, et al: Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res 62:1184-1190, 2002
36. Bockmuhl U, Ishwad CS, Ferrell RE, et al: Association of 8p23 deletions with poor survival in head and neck cancer. Otolaryngol Head Neck Surg 124:451-455, 2001
37. Singh B, Stoffel A, Gogineni S, et al: Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas. Am J Pathol 161:365-371, 2002